This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Henry H. Balfour, Jr, MD; Karl E. Groth; Jeffrey McCullough, MD; Janal M. Kalis; Stephen C. Marker, MD; Mark E. Nesbit, MD; Richard L. Simmons, MD; John S. Najarian, MD

Am J Dis Child. 1977;131(6):693-696.

Abstract
• Zoster immune plasma (ZIP) was given to 31 susceptible immunocompromised children one to seven days (median, two days) following household, playmate, or hospital exposures to varicella. The average amount of ZIP transfused was 7 ml/kg. Twenty-one children did not develop varicella or persistent antibodies to varicella-zoster virus (VZV). Eight (26%) of the 31 contracted clinical varicella. Seven cases were mild, but in one child, who was given ZIP seven days after exposure, visceral disease developed and the child died. Two children had subclinical varicella that was documented by persistence of VZV antibodies for at least ten months after passive immunization. Because none of the 30 children given ZIP one to six days following exposure had severe varicella, we conclude that ZIP is effective in preventing or modifying varicella in immunocompromised patients if given shortly after exposure.

(Am J Dis Child 131:693-696, 1977)

Author Affiliations
From the Departments of Laboratory Medicine and Pathology, Surgery, and Pediatrics, University of Minnesota Health Sciences Center, Minneapolis.

Footnotes
Reprint requests to Box 437 Mayo, University of Minnesota Health Sciences Center, Minneapolis, MN 55455 (Dr Balfour).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Varicella-Zoster Antibody Titers in Children With Leukemia and Lymphoma: Relationship of Titer to Varicella-Zoster Infection
Hutter et al.
Arch Pediatr Adolesc Med 1984;138:56-59.
ABSTRACT  

Varicella in the Immunocompromised Host
Preblud et al.
JAMA 1978;239:2551-2552.
ABSTRACT  

Evaluation of Zoster Immune Plasma: Treatment of Cutaneous Disseminated Zoster in Immunocompromised Patients
Groth et al.
JAMA 1978;239:1877-1879.
ABSTRACT